1Cademy - Cancer Immunotherapy | Checkpoint Inhibitors against PD-1 and PD-L1

Relation

Cancer Immunotherapy | Checkpoint Inhibitors against PD-1 and PD-L1

PD-1 is a checkpoint protein on T cells (a type of immune cell).
"When PD-1 binds to PD-L1, it basically tells the T cell to leave the other cell alone. Some cancer cells have large amounts of PD-L1, which helps them hide from an immune attack" (cancer.org).
Checkpoint inhibitors that inhibit PD-1 and/or PD-L1 have great potential in battling certain cancers.
Image from NIH - National Cancer Institute